Back to WA Weiss Asset Management LP

AVDLAVDL

2 quarters

Position history for WAWeiss Asset Management LP's holdings in AVADEL PHARMACEUTICALS

As of its Q4 2025 13F, Weiss Asset Management held 4,515,114 shares of AVDL (Avadel Pharmaceuticals), worth $97.3M. AVDL was 1.3% of Weiss Asset Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$97.3M

Total Shares Change

-4.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q4
New
4.5M
—
$97.3M1.3%—
68

Optional analytics helps us improve. How it’s used